Vivaldi Asset Management »

Astria Therapeutics shares owned by Vivaldi Asset Management

Quarter-by-quarter ownership of Astria Therapeutics shares owned by Vivaldi Asset Management from 13F filings

Historical chart of Vivaldi Asset Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Vivaldi Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Vivaldi Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 831k 13.09

More positions owned by Vivaldi Asset Management

Cadence Bank Equity
Cyberark Software Equity (CYBR)
Dayforce Equity
Comerica Equity
Alexander & Baldwin Equity (ALEX)
Cidara Therapeutics Equity (CDTX)
Hillenbrand Equity (HI)
Synovus Finl Corp Equity (SNV)
Clearwater Analytics Hldgs I Equity (CWAN)
Aa Mission Acquisition Corp Equity
Agriculture & Nat Sol Acq Equity (ANSC)
Centurion Acquisition Corp Equity (ALF)
Exact Sciences Corp Equity (EXAS)
Sealed Air Corp Equity (SEE)
Drugs Made In Amer Acqutn Equity (DMAA)

View all positions for Vivaldi Asset Management

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics